Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-14-035924

Options or other derivatives

  • Senior VP - Drug Discovery acquired 17,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-12-19 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +17,000 $5.45 2023-08-08 17,000 17,000 D
Loading xslF345X03/form4.xml…